It promotes fibrin cross-linking and mediates the binding of the pathogens to platelets,, resulting in thrombus (blood clot) formation.
This response is activated by components of the wall of invading micro-organisms, such as lipopolysaccharide (LPS) or peptidoglycan, following the binding of these pathogen-associated molecular patterns to pattern recognition receptors, such as the Toll-like receptors (TLRs) on tissue macrophages.
Monocytes as well as type 1 macrophages (Mφ1) produce IL-23 in response to the binding of pathogens and pathogen-associated molecular patterns (PAMPs), such as lipopolysaccharide (LPS), to Toll-like receptors (TLRs) [5], [6].
Indeed, the binding of a pathogen by antibody to a receptor on the cell membrane can promote macrophage uptake through Fc receptors [24].
This can be induced by the binding of neisserial pathogens to the granulocyte-specific CEACAM3 followed by rapid stimulation of the GTPase Rac, eventually leading to phagocytosis and killing of the bacteria [ 20].
These results demonstrated that expression of nucleolin is essential for LVS binding and that nucleolin does not participate to the binding of another pathogen like L. monocytogenes or inert particles like fluorescent beads.
The CP activation is initiated by binding of antibody to the C1 complex, formed by C1q and two serine proteases (C1r and C1s), or by direct binding of the C1q component to the pathogen surface, and requires both Ca2+ and Mg2+ [2]–[4].
The CP activation is initiated by binding of antibody to the C1 complex, formed by C1q and two serine proteases (C1r and C1s), or by direct binding of the C1q component to the pathogen surface, and requires both Ca2+ and Mg2+ [4]–[6].
Interestingly, HMOs are produced by mothers not for direct nourishment of their infants, but instead have other biological functions such as inhibiting the binding of pathogens, stimulating the growth of commensal intestinal bacterial, and promoting postnatal brain development.
